Objective To observe the clinical efficacy of Gelomyrtol Forte assisted with ultrashort wave therapy on secretory otitis media（SOM）.Method 80cases of patients with secretory otitis media were randomly divided into the experimental group and the control group with 40cases in each group.Both groups were given conventional medical treatment but oral Gelomyrtol Forte with ultrashort wave therapy were added to the treatment of the experimental group.After two to three weeks

symptoms

physical signs

changes in pure tone audiometry and tympanogram were observed during the follow-up examination before and after the treatment.The efficacy of the two groups was compared.Results For the efficacy of the experimental group

27 cases were excellent

eight cases were effective

5cases were ineffective and the total effective rate was 87.5%;while for the efficacy of the control group

16cases were excellent

14cases were effective

10cases were ineffective and the total effective rate was 75.0%.The differences in the two groups were statistically significance（P<0.05）.With the extension of the course of SOM

the efficacy of these patients decreased in tandem.Conclusion Oral Gelomyrtol Forte assisted with ultrashort wave treatment can effectively improve the clinical efficacy of SOM and this treatment has a better effect on patients of short SOM history without or with less tympanic effusion.It is worthy of clinical promotion.